Contract facts
SBANo full NAICS 325412 intel page yet. Browse NAICS intelligence
CGMP CLINICAL SUPPLIES MANUFACTURING QUALIFICATION AND STABILITY TESTING OF TARP 1-20 AND 21-40 ME TARP PEPTIDE AND TWS… is a federal SBA award for Nih Nci held by Irisys LLC. Estimated value $127.1M ($76.1M obligated). Current period of performance ends Jan 31, 2025. Last award drew 1 bidder. Place of performance: SAN DIEGO, CA. Related solicitation N02CM5700205.
CGMP CLINICAL SUPPLIES MANUFACTURING QUALIFICATION AND STABILITY TESTING OF TARP 1-20 AND 21-40 ME TARP PEPTIDE AND TWS-119 STABILITY STUDY PERIOD OF PERFORMANCE: 09/27/2019 - 09/26/2022
Recompete timing
PublicCurrent PoP ended Jan 31, 2025 (566 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N91019F00133?
75N91019F00133 (CGMP clinical supplies manufacturing) is a Nih Nci award with an estimated value of $127.1M, currently held by Irisys LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N91019F00133?
Nih Nci awarded 75N91019F00133 to Irisys LLC.
Who is the incumbent on 75N91019F00133?
Irisys LLC is the incumbent. The current period of performance ends Jan 31, 2025.
When does Irisys LLC’s 75N91019F00133 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 31, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.